These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24175973)

  • 1. Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor.
    Du Q; Wu J; Wang H; Wang X; Xu L; Zhang Z; Liu J; Zhang J; Chen J; Hakonarson H; Hu A; Zhang L
    BMC Cardiovasc Disord; 2013 Oct; 13():94. PubMed ID: 24175973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
    Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L
    Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Autoantibody against M2-Muscarinic Acetylcholine Receptor in Heart Failure Patients on Digoxin Treatment.
    Hou D; Fan Z; Xu L; Wang H; Zhang Z; Ma G; Xu X; Wang X; Zhang J; Liu J; Zhang L
    Cardiology; 2018; 141(1):9-17. PubMed ID: 30293082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
    Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Gray CS; Lye M; O'Mahony D; Polonski L; Taylor J
    Eur J Heart Fail; 1999 Aug; 1(3):211-7. PubMed ID: 10935667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perindopril treatment for congestive heart failure.
    Sonnenblick EH
    Am J Cardiol; 2001 Oct; 88(7A):19i-27i. PubMed ID: 11591357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE; McKinnie JJ; Greenberg SS; Giles TD
    Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of postinfarction left ventricular remodeling during long term use of perindopril, amiodarone, and beta-adrenoblockers].
    Kanorskiĭ SG; Staritskiĭ AG; Bozhko AA
    Kardiologiia; 2005; 45(3):31-5. PubMed ID: 15821705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism.
    Brunner-La Rocca HP; Vaddadi G; Esler MD
    J Am Coll Cardiol; 1999 Apr; 33(5):1163-73. PubMed ID: 10193712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
    Luo J; Chen X; Luo C; Lu G; Peng L; Gao X; Zuo Z
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perindopril on left ventricular remodeling and aortic regurgitation in rats assessed by echocardiography.
    Murakami K; Mizushige K; Noma T; Kimura S; Abe Y; Matsuo H
    Angiology; 2000 Nov; 51(11):943-52. PubMed ID: 11103863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.